( MacDougall Biomedical Communications, Inc. ) Emerald BioStructures announced today a publication in the Dec. 27, 2009, advance online issue of Nature Biotechnology, detailing the application of structure-based drug design to engineer new allosteric small molecule modulators of the enzyme phosphodiesterase-4 (PDE4), with reduced side effects. According to the paper, the researchers established …
Read the rest here:
Emerald BioStructures announces discovery of small molecule modulators of PDE4 (EurekAlert!)
